Don't Wait to Innovate: Future Pharmaceuticals Magazine Releases Its Issue on Innovation...

Don't Wait to Innovate: Future Pharmaceuticals Magazine Releases Its Issue on
Innovation in IT, Cell-Based Therapy and Supply Chains

NEW YORK, Sept. 9 /PRNewswire/ -- Future Pharmaceuticals features an exclusive
interview with Dave Champagne, Vice President and General Manager of
Informatics at Thermo Fisher Scientific, and Thor-Gunnar Steinsli, LIMS
Manager and Chief Engineer at HUNT Research Center and Biobank, about data
integration: the benefits of data, instrument and enterprise integration
strategies and challenges at life sciences companies.

"One of the biggest challenges facing life sciences companies has to do with
managing the ever-growing volume of data and connecting all of the disparate
sources of data throughout an organization," Champagne said.

"HUNT Biobank is a vivid example of the benefits of this type of integrated
solution who helped us secure Microsoft's prestigious Pharmaceutical and Life
Sciences Innovation Award in Discovery and Product Innovation (for more
information visit http://www.thermo.com/informatics)," Champagne added.

The Director of Global Quality Labs at Eli Lilly, Jackie Larew, is featured in
this issue leading an expert panel around issues facing the supply chain. One
of the questions she poses to the panel is around the recent concerns we've
seen with pet food and milk products tainted with melamine and contaminated
heparin entering the U.S. supply chain. "What implications does this have for
the way pharmaceutical companies ensure quality from their suppliers with an
increasingly global supply chain of raw materials?" Larew asked the panelists.

This edition of FP also delves into the changing world of cell-based therapy.
Mark Thiede, Research Fellow with Pfizer for the Genetically Modified Models
Center of Emphasis, guest moderates a panel discussion on the future of the
cellular therapy industry. Read the piece, Diagnosis: Cell-based Therapy, for
their insights.

About Future Pharmaceuticals
Future Pharmaceuticals magazine draws connections between industry leaders and
pharmaceutical companies. Future Pharmaceuticals recommends next generation
and groundbreaking strategies to ensure success across the enterprise.

About Analysts In Media
AIM Inc., headquartered in New York City, is a leading global provider of
high-quality, comprehensive information for the professional and enthusiast
markets. Through progressive research, surveys and client case studies from
visionaries and leaders in the industry, AIM provides access to its validated
knowledge via targeted multi-media channels, publications, events and online
services.

For more information, visit www.FuturePharmaUS.com

SOURCE Future Pharmaceuticals

Farrah Tuttle, +1-646-747-7783, or Jamie Devereaux, +1- 646-747-7462, both for
Future Pharmaceuticals